Top Companies in the Cold Plasma Market
- neoplas tools GmbH
- Adtec Medical
- Apyx Medical
- Bovie Medical / Apyx
- Erbe Elektromedizin
- Olympus / Pentax / major endoscopy OEMs
- PlasmaDerm
- Cynosure / Hologic
- Plasmacure / small-to-mid startups
- Cryoplas / industrial plasma OEMs
- Cold Plasma Research Centers
- Atmospheric plasma OEMs for surface treatment
- Sterilization & Disinfection service providers using plasma
- Medical device contract manufacturers/integrators
- Plasma-to-liquid / plasma-activated liquid developers
- Dental plasma device startups
- Veterinary device vendors
- Air & HVAC plasma/UV integrators
- Consumable applicator & single-use tip suppliers
- Clinical trial & service CROs specializing in plasma medicine trials
Market Growth
The global cold plasma market size touched US$ 2.92 billion in 2024, with expectations of climbing to US$ 3.34 billion in 2025 and hitting US$ 11.14 billion by 2034, driven by a CAGR of 14.35% over the forecast period.
What are the Key trends in the Cold Plasma Market in 2024?
Sustainability Focus – Collaborative projects are developing eco-friendly, chemical-free plasma technologies, meeting regulatory and environmental standards.
- In December 2024, Germany’s Relyon Plasma GmbH partnered with Viromed Medical GmbH to advance research on cold atmospheric pressure plasma in medical applications. Relyon Plasma focuses on developing the technology, while Viromed handles device approval and distribution, combining expertise to accelerate clinical adoption.
Technological Advancements – Innovations in portable, cost-effective, and automated plasma devices are expanding usability.
- In April 2024, Singapore’s Mirari Doctor PTE LTD launched the portable MIRARI Cold Plasma System for skin rejuvenation and wound healing. Approved by the Thai FDA and Vietnam’s Ministry of Health, the device provides healthcare professionals with a versatile, easy-to-use solution applicable in dermatology, wound care, and potential cancer therapy treatments.
Cold Plasma Market Value Chain Analysis
R&D
R&D in cold plasma is centered on using its non-thermal, environmentally friendly reactive species for healthcare applications, such as sterilization, wound therapy, and cancer treatment, as well as in the food industry for decontamination, preservation, and improving food quality and functionality.
Packaging and Sterilization
Cold plasma treatment packaging uses specialized materials, such as biopolymers or cellulose, to hold food while allowing plasma to improve surface characteristics or perform in-package microbial decontamination. Serialization adds unique identifiers to track products through the supply chain, ensuring safety and integrity, and can be integrated with cold plasma packaging processes for enhanced quality control.
Patient Support and Services
Patient support for cold plasma treatments includes clinical evaluations to confirm suitability, access to specialized centers like Germanten Hospital, continuous monitoring by healthcare professionals, and follow-up care to manage side effects and evaluate treatment outcomes.
Latest Announcement by Industry Leaders
In June 2025, Hyped About Science launched PHLAS, the first professional-grade cold plasma skincare device for home use, on Kickstarter. Based on Max Planck research, the chemical-free, anti-inflammatory device targets skin issues like acne. It exceeded funding goals by over 400%, highlighting strong consumer demand and representing a significant milestone in the commercial adoption of cold plasma technology.
Recent Developments in the Cold Plasma Market
- In June 2025, Comau partnered with Intecells to advance cold plasma applications in industrial cell manufacturing. Using Intecells’ patented technology, the collaboration focuses on developing cost-effective solutions for integrating cold plasma into existing cell production processes.
- In February 2024, Adtec Healthcare visited Taiwan to progress its SteriPlas expansion, enhancing cold plasma technology for sterilization. The initiative aims to boost the company’s presence in Asia and meet rising demand for innovative healthcare solutions, demonstrating its commitment to improving medical standards through advanced sterilization methods and strategic partnerships.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
